hh-003
mAbexperimental
Clinical trial activity
5 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Aug 5, 2019 (NCT05542979)
Timeline
Indications
Mechanism of action
- Hepatitis B virusANTAGONIST
Hepatitis B virus antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05861674 | Phase 2 | Jun 16, 2023 | Huahui Health |
| NCT05734807 | Phase 2 | Jul 20, 2022 | Huahui Health |
| NCT05839639 | Phase 2 | Oct 9, 2021 | Huahui Health |
| NCT05674448 | Phase 2 | Aug 11, 2021 | Huahui Health |
| NCT05542979 | Phase 1 | Aug 5, 2019 | Huahui Health |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Huahui Health | Academic/Hospital | 5 | 5 | 2 | 2019 |
1 organizations
Page 1 / 1